Cargando…

Targeting Genome Stability in Melanoma—A New Approach to an Old Field

Despite recent groundbreaking advances in the treatment of cutaneous melanoma, it remains one of the most treatment-resistant malignancies. Due to resistance to conventional chemotherapy, the therapeutic focus has shifted away from aiming at melanoma genome stability in favor of molecularly targeted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osrodek, Marta, Wozniak, Michal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036881/ https://www.ncbi.nlm.nih.gov/pubmed/33800547 http://dx.doi.org/10.3390/ijms22073485

Ejemplares similares

Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma Cells
por: Osrodek, Marta, et al.
Publicado: (2020)

Physiologically Relevant Oxygen Concentration (6% O(2)) as an Important Component of the Microenvironment Impacting Melanoma Phenotype and Melanoma Response to Targeted Therapeutics In Vitro
por: Osrodek, Marta, et al.
Publicado: (2019)

New Approaches to Targeted Therapy in Melanoma
por: Fernandez, Manuel Felipe, et al.
Publicado: (2023)

Plasticity of Drug-Naïve and Vemurafenib- or Trametinib-Resistant Melanoma Cells in Execution of Differentiation/Pigmentation Program
por: Czyz, Malgorzata, et al.
Publicado: (2019)

Exogenous growth factors bFGF, EGF and HGF do not influence viability and phenotype of (V600E)BRAF melanoma cells and their response to vemurafenib and trametinib in vitro
por: Zalesna, Izabela, et al.
Publicado: (2017)

Zonnic®: a new player in an old field
por: Gong, Min, et al.
Publicado: (2017)

17-Aminogeldanamycin selectively diminishes IRE1α-XBP1s pathway activity and cooperatively induces apoptosis with MEK1/2 and BRAF(V600E) inhibitors in melanoma cells of different genetic subtypes
por: Mielczarek-Lewandowska, Aleksandra, et al.
Publicado: (2019)

The Functional Role of Long Non-Coding RNAs in Melanoma
por: Wozniak, Michal, et al.
Publicado: (2021)

PKC in Regenerative Therapy: New Insights for Old Targets
por: Rui, Marta, et al.
Publicado: (2017)

lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma
por: Wozniak, Michal, et al.
Publicado: (2023)

Nucleoli cytomorphology in cutaneous melanoma cells – a new prognostic approach to an old concept
por: Donizy, Piotr, et al.
Publicado: (2017)

Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma—Old Myth or New Logos?
por: Meraz-Torres, Francisco, et al.
Publicado: (2020)

Targeted Therapy in Melanoma and Mechanisms of Resistance
por: Czarnecka, Anna M., et al.
Publicado: (2020)

Pathways and therapeutic targets in melanoma
por: Shtivelman, Emma, et al.
Publicado: (2014)

Heterogeneity in Cancer Metabolism: New Concepts in an Old Field
por: Gentric, Géraldine, et al.
Publicado: (2017)

Old and New Precipitants in Hepatic Encephalopathy: A New Look at a Field in Continuous Evolution
por: Bellafante, Daniele, et al.
Publicado: (2023)

VISTA, PDL-L1, and BRAF—A Review of New and Old Markers in the Prognosis of Melanoma
por: Tinca, Andreea Cătălina, et al.
Publicado: (2022)

Malolactic Fermentation: New Approaches to Old Problems
por: Fu, Junwei, et al.
Publicado: (2022)

Nucleic acids delivery methods for genome editing in zygotes and embryos: the old, the new, and the old-new
por: Sato, Masahiro, et al.
Publicado: (2016)

Enhancing Therapeutic Approaches for Melanoma Patients Targeting Epigenetic Modifiers
por: Gracia-Hernandez, Maria, et al.
Publicado: (2021)

Targeting ERβ to fight melanoma: a new valid approach?
por: Di Donato, Marzia, et al.
Publicado: (2022)

Melanoma Targeted Therapies beyond BRAF-Mutant Melanoma: Potential Druggable Mutations and Novel Treatment Approaches
por: Khaddour, Karam, et al.
Publicado: (2021)

Malignant gliomas: old and new systemic treatment approaches
por: Mesti, Tanja, et al.
Publicado: (2016)

Exhaled biomarkers in childhood asthma: old and new approaches
por: Ferraro, Valentina, et al.
Publicado: (2018)

Old and New Approaches to Animal Cognition: There Is Not “One Cognition”
por: Bräuer, Juliane, et al.
Publicado: (2020)

Rheumatoid arthritis: the old issue, the new therapeutic approach
por: Babaahmadi, Mahnaz, et al.
Publicado: (2023)

Diagnosis of Parasitic Diseases: Old and New Approaches
por: Ndao, Momar
Publicado: (2009)

Breast Cancer Chemoprevention: Old and New Approaches
por: Cazzaniga, Massimiliano, et al.
Publicado: (2012)

Targeting HER3 for cancer treatment: a new horizon for an old target
por: Uliano, J., et al.
Publicado: (2023)

NSAIDs: Old Drugs Reveal New Anticancer Targets
por: Piazza, Gary A., et al.
Publicado: (2010)

Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities
por: Laface, Carmelo, et al.
Publicado: (2022)

Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach
por: Ricciardi, Elena, et al.
Publicado: (2023)

Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives
por: Croce, Michela, et al.
Publicado: (2019)

Personalized medicine: new genomics, old lessons
por: Offit, Kenneth
Publicado: (2011)

Spironolactone and XPB: An Old Drug with a New Molecular Target
por: Gabbard, Ryan D., et al.
Publicado: (2020)

Acral melanoma: new insights into the immune and genomic landscape
por: Carvalho, Larissa Anastacio DaCosta, et al.
Publicado: (2023)

Old concepts, new molecules and current approaches applied to the bacterial nucleotide signalling field
por: Gründling, Angelika, et al.
Publicado: (2016)

Targeting Asporin in Lung Fibrosis: A New Approach to an Old Concept
por: He, Chao, et al.
Publicado: (2021)

New Molecules and Old Drugs as Emerging Approaches to Selectively Target Human Glioblastoma Cancer Stem Cells
por: Würth, Roberto, et al.
Publicado: (2014)

Inhibition of Hemorragic Snake Venom Components: Old and New Approaches
por: Panfoli, Isabella, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_mn60dgijcng6ulife5290uf3h1